Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:BRW NYSE:SNN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBRWSaba Capital Income & Opportunities Fund$6.55-0.3%$6.78$6.38▼$8.49N/AN/A255,107 shs260,487 shsSNNSmith & Nephew SNATS$30.52-0.5%$31.33$28.40▼$38.79$13.04B0.551.12 million shs698,105 shs5G Stocks: The Path Forward is ProfitableClick the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBRWSaba Capital Income & Opportunities Fund+1.08%-2.95%-3.38%+1.70%-15.23%SNNSmith & Nephew SNATS-0.83%-0.60%+2.20%-6.69%+1.89%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBRWSaba Capital Income & Opportunities Fund$6.55-0.3%$6.78$6.38▼$8.49N/AN/A255,107 shs260,487 shsSNNSmith & Nephew SNATS$30.52-0.5%$31.33$28.40▼$38.79$13.04B0.551.12 million shs698,105 shs5G Stocks: The Path Forward is ProfitableClick the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBRWSaba Capital Income & Opportunities Fund+1.08%-2.95%-3.38%+1.70%-15.23%SNNSmith & Nephew SNATS-0.83%-0.60%+2.20%-6.69%+1.89%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBRWSaba Capital Income & Opportunities Fund 0.00N/AN/AN/ASNNSmith & Nephew SNATS 2.17Hold$30.931.32% UpsideCurrent Analyst Ratings BreakdownLatest JAGI, BRW, SSON, and SNN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/11/2026SNNSmith & Nephew SNATS Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C+) ➝ Hold (C)6/4/2026SNNSmith & Nephew SNATS Kepler Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy ➝ Hold5/25/2026SNNSmith & Nephew SNATS The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy5/11/2026SNNSmith & Nephew SNATS Sanford C. BernsteinSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$31.855/11/2026SNNSmith & Nephew SNATS Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetHold$32.00 ➝ $30.004/24/2026SNNSmith & Nephew SNATS Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$32.004/20/2026SNNSmith & Nephew SNATS Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C+)(Data available from 6/12/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBRWSaba Capital Income & Opportunities Fund$58.12MN/AN/AN/AN/AN/ASNNSmith & Nephew SNATS$6.16B2.10$3.41 per share8.94$12.45 per share2.45Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBRWSaba Capital Income & Opportunities FundN/AN/AN/AN/AN/AN/AN/AN/AN/ASNNSmith & Nephew SNATS$625MN/AN/A12.261.02N/AN/AN/A8/4/2026 (Estimated)Compare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBRWSaba Capital Income & Opportunities Fund$1.1016.68%N/AN/AN/ASNNSmith & Nephew SNATS$0.933.05%N/AN/AN/ALatest JAGI, BRW, SSON, and SNN DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/29/2026BRWSaba Capital Income & Opportunities Fundmonthly$0.085015.38%6/9/20266/9/20266/30/20264/30/2026BRWSaba Capital Income & Opportunities Fundmonthly$0.085015.04%5/11/20265/11/20265/29/20263/31/2026BRWSaba Capital Income & Opportunities Fundmonthly$0.085015.29%4/13/20264/13/20264/30/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBRWSaba Capital Income & Opportunities FundN/AN/AN/ASNNSmith & Nephew SNATS0.602.571.25Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBRWSaba Capital Income & Opportunities FundN/ASNNSmith & Nephew SNATS25.64%Insider OwnershipCompanyInsider OwnershipBRWSaba Capital Income & Opportunities FundN/ASNNSmith & Nephew SNATS1.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBRWSaba Capital Income & Opportunities FundN/AN/AN/ANot OptionableSNNSmith & Nephew SNATS16,988425.11 million422.76 millionOptionableJAGI, BRW, SSON, and SNN HeadlinesRecent News About These CompaniesSmith & Nephew plc (SNN) Shareholder/Analyst Call TranscriptJune 11 at 9:12 AM | seekingalpha.comSmith & Nephew's robotics push wins surgeon backingJune 10 at 11:30 AM | proactiveinvestors.co.ukSmith & Nephew plc (SNN) Shareholder/Analyst Call - SlideshowJune 9 at 4:34 AM | seekingalpha.comSmith+Nephew announces first clinical cases with the next generation CORI◊XT Handheld Robotics Platform across knee and shoulder arthroplastyJune 8, 2026 | globenewswire.comSmith+Nephew launch next generation LEAF™ Patient Monitoring System – an innovative pressure injury prevention platform delivering proven clinical impactJune 1, 2026 | globenewswire.comSmith & Nephew SNATS IncMay 26, 2026 | 247wallst.comVEEV Boosts MedTech Quality Management With Smith+Nephew PartnershipMay 13, 2026 | zacks.comSmith & Nephew plc (SNN) Q1 2026 Sales/Trading Call TranscriptMay 6, 2026 | seekingalpha.comSmith+Nephew initiates $500M share buyback with Q1 sales beatMay 6, 2026 | massdevice.comSmith & Nephew plc (SNN) Q1 2026 Sales/ Trading Statement Call - SlideshowMay 6, 2026 | seekingalpha.comUK's Smith+Nephew keeps annual outlook, plans share buyback as quarterly revenue risesMay 6, 2026 | reuters.comSmith+Nephew drives progress in chronic wound care with ALLEVYN™COMPLETE CARE Dressing and RENASYS™ EDGE tNPWT set to launch at EWMA 2026May 5, 2026 | globenewswire.comSNN vs. BSX: Which Stock Is the Better Value Option?May 5, 2026 | zacks.comCanaccord Cuts PT on Smith & Nephew (SNN) Ahead of Fiscal Q1 ResultsMay 1, 2026 | insidermonkey.comSNN's CARTIHEAL Cartilage Implant Beats Standard Care in 5-Year StudyApril 24, 2026 | zacks.comSNN Launches ALLEVYN COMPLETE CARE Dressing for Wound ManagementMarch 11, 2026 | zacks.comSmith+Nephew launches next-generation ALLEVYN™ COMPLETE CARE Foam Dressing - designed for high performance in wound management and pressure injury preventionMarch 10, 2026 | globenewswire.comSmith & Nephew Posts Strong 2025 Results and Unveils Next-Phase Growth StrategyMarch 6, 2026 | theglobeandmail.comSmith+Nephew to showcase advanced Orthopaedic Handheld Robotics, Reconstruction and Trauma technologies during AAOS 2026March 3, 2026 | globenewswire.comSmith & Nephew plc (NYSE:SNN) Q4 2025 Earnings Call TranscriptMarch 3, 2026 | insidermonkey.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeJAGI, BRW, SSON, and SNN Company DescriptionsSaba Capital Income & Opportunities Fund NYSEARCA:BRW$6.55 -0.02 (-0.30%) Closing price 04:10 PM EasternExtended Trading$6.67 +0.12 (+1.82%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Saba Capital Income & Opportunities Fund is a closed-ended fixed income mutual fund launched by Voya Investment Management LLC. The fund is managed by Saba Capital Management, L.P. It invests in the fixed income markets of the United States. The fund seeks to invest in securities of companies operating across diversified sectors. It primarily invests in floating rate secured senior loans, with an emphasis on top-tier, non-investment grade senior loans. The fund seeks to invest in loans with maturities of one to ten years. It benchmarks the performance of its portfolio against the S&P/LSTA Leveraged Loan Index. The fund was formerly known as Voya Prime Rate Trust. Saba Capital Income & Opportunities Fund was formed on December 2, 1987 and is domiciled in the United States.Smith & Nephew SNATS NYSE:SNN$30.52 -0.15 (-0.49%) Closing price 03:59 PM EasternExtended Trading$30.51 -0.01 (-0.02%) As of 06:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SpaceX Rings the Bell and Shatters Every Record Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story? ERock IPO: A $1.3B Power Play Solution Boeing’s Unseen Rebound: Why the Headlines Are Wrong Why Oracle's 10% Drop May Be Telling the Wrong Story Spotify's "North Star" Outlook Was Music to Investors Ears DraftKings Hits the Jackpot With Super App Pivot Cracker Barrel Surges 23% as Earnings Beat Signals Turnaround Progress Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
